Nanosonics(OTC) NNCSF

Market Cap$576.90M

Since IPO (2010)+101%

5 Year-60%

1 Year-37%

1 Month-12%

$1.93

-0.52%

-0.01Today

Nanosonics last closing stock price
Metric	Price	Date
Last close	USD 1.93	2026-09-01

Nanosonics stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-16.09%	USD 2.30	2026-08-25
1 month	-11.87%	USD 2.19	2026-07-23
3 month	-22.8%	USD 2.50	2026-05-27
Year to date	-33.45%	USD 2.90	2025-12-18
1 year	-36.72%	USD 3.05	2025-08-29
3 year	-34.58%	USD 2.95	2023-08-25
5 year	-60.38%	USD 4.87	2021-08-27
Since inception	+101.04%	USD 0.96	2010-11-05

Nanosonics Financials at a Glance

Market Cap

$576.90M

Revenue (TTM)

A$401.80M

Net Income (TTM)

A$38.50M

EPS (TTM)

$0.04

P/E Ratio

48.37

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$1.93

Volume

675

Open

$1.93

Price

$1.93

Volume

675

Open

$1.93

Previous Close

$1.93

Daily Range

$1.93 - $1.93

52-Week Range

$1.93 - $3.06

Estimated Earnings Date

Feb 23, 2027

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$1.93

Volume

675

Open

$1.93

Previous Close

$1.93

Daily Range

$1.93 - $1.93

52-Week Range

$1.93 - $3.06

Estimated Earnings Date

Feb 23, 2027

NNCSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanosonics

Nanosonics Limited is an innovative infection prevention company that operates in both Australian and international markets. The company specializes in the production and supply of advanced disinfection technologies, particularly for ultrasound probes, enhancing safety in medical environments.

Products and Services

trophon2: A device for high-level disinfection of ultrasound probes
trophon EPR: A low-temperature disinfection solution for intra-cavity ultrasound transducers
Nanosonics AuditPro: A system for managing compliance with infection control workflows

Growth Outlook

Strong demand for infection control solutions is expected to drive revenue growth
Expansion into international markets presents significant growth opportunities
Investment in R&D aims to enhance product offerings and market reach

Financial Highlights

Recent quarterly revenue of AUD 100.86 million reflects robust market performance
Net income for the latest quarter reached AUD 8.18 million, showcasing profitability
Cash and cash equivalents stand at AUD 155 million, indicating strong liquidity

Nanosonics Limited has established itself as a leader in infection prevention technologies, particularly in the healthcare sector. The company's commitment to innovation is evident in its diverse product offerings, which cater to the growing need for effective disinfection solutions. Recent financial performance highlights a strong revenue stream and profitability, supported by a solid cash position. The outlook for growth remains positive, driven by increasing global demand for infection control products and strategic investments in research and development. As the healthcare landscape continues to evolve, Nanosonics is well-positioned to capitalize on emerging opportunities in the infection prevention market.

AI Generated • Aug 27, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

508

CEO

Michael Kavanagh, MBA

Website

www.nanosonics.com.au

Headquarters

Macquarie Park, NSW 2113, AU

NNCSF Financials

Key Financial Metrics (TTM)

Gross Margin

76.86%

Operating Margin

7.37%

Net Income Margin

8.77%

Return on Equity

8.16%

Return on Capital

6.23%

Return on Assets

5.74%

Earnings Yield

2.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$576.90M

Shares Outstanding

298.91M

Volume

675

Avg. Volume

477.078

Financials (TTM)

Gross Profit

A$311.49M

Operating Income

A$33.52M

EBITDA

A$49.72M

Operating Cash Flow

A$66.51M

Capital Expenditure

-A$13.85M

Free Cash Flow

A$52.65M

Cash & ST Invst.

A$155.00M

Total Debt

A$23.10M

Nanosonics Performance Analysis

Nanosonics annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-06-30	AUD 112,688,097	29.8%
2024	2024-06-30	AUD 112,436,794	-0.2%
2025	2025-06-30	AUD 128,442,711	14.2%
2026	2026-06-30	AUD 137,873,229	7.3%

Nanosonics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-12-31	4.7%
Q4	2025-06-30	12.1%
Q2	2025-12-31	-2.4%
Q4	2026-06-30	-1.5%

Nanosonics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-06-30	AUD 0.04	391.0%
2024	2024-06-30	AUD 0.03	-37.1%
2025	2025-06-30	AUD 0.04	57.5%
2026	2026-06-30	AUD 0.04	-9.7%

Nanosonics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-12-31	-1.2%
Q4	2025-06-30	11.7%
Q2	2025-12-31	-11.6%
Q4	2026-06-30	-15.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

A$100.86M

+12.9%

Gross Profit

A$78.03M

+14.8%

Gross Margin

77.37%

N/A

Market Cap

$576.90M

N/A

Market Cap/Employee

$1.14M

N/A

Employees

508

N/A

Net Income

A$8.18M

+20.2%

EBITDA

A$10.87M

-33.0%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

A$155.00M

+19.6%

Total Debt

A$23.10M

+148.3%

Accounts Receivable

A$46.62M

+17.5%

Inventory

A$27.55M

+36.2%

Long Term Debt

A$20.14M

+226.9%

Short Term Debt

A$2.95M

-5.9%

Return on Assets

5.74%

N/A

Return on Invested Capital

5.61%

N/A

Free Cash Flow

A$13.05M

+5.6%

Operating Cash Flow

A$15.94M

+15.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TDVXFTobii Dynavox AB (publ)

TDVXFTobii Dynavox AB (publ)$7.50+0.00%

PHCIPanamera Holdings Corporation

PHCIPanamera Holdings Corporation$2.50+0.00%

TGLVYTop Glove Corporation Bhd.

TGLVYTop Glove Corporation Bhd.$0.55+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.15-0.12%

NVDANvidia

NVDANvidia$230.36+0.01%

PATHUiPath

PATHUiPath$15.19-0.17%

INTCIntel

INTCIntel$95.80+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.13+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.74-0.02%

TSLATesla

TSLATesla$354.08-0.06%

Questions About NNCSF

What is the current price of Nanosonics?

Nanosonics is trading at $1.93 per share.

What is the 52-week range for Nanosonics?

Over the past 52 weeks, Nanosonics has traded between $1.93 and $3.06.

How much debt does Nanosonics have?

As of the most recent reporting period, Nanosonics reported total debt of A$16.03M.

How much cash does Nanosonics have on hand?

Nanosonics reported A$107.54M in cash and cash equivalents in its most recent financial results.

What is Nanosonics’s dividend yield?

Nanosonics does not currently have a dividend yield.

Nanosonics(OTC) NNCSF

Nanosonics Financials at a Glance

NNCSF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nanosonics

NNCSF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nanosonics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NNCSF

What is the current price of Nanosonics?

What is the 52-week range for Nanosonics?

How much debt does Nanosonics have?

How much cash does Nanosonics have on hand?

What is Nanosonics’s dividend yield?

Premium Investing Services